Physician profile
Billy D Preuninger
NPI 1861683526
$352.15
in general payments reported to CMS, 2019-2025
10 companies · $73.96 in 2025
The $73.96 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.84 · 2021: $11.95 · 2022: $65.59 · 2023: $37.13 · 2024: $135 · 2025: $73.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $81.94 | 2024-2025 | Myfembree |
| Astellas Pharma US INC | $60.59 | 2022-2024 | Veozah |
| Pfizer INC. | $44.42 | 2024-2025 | |
| Shield Therapeutics INC | $31.36 | 2022-2023 | Accrufer |
| Aspira Women'S Health INC | $30.66 | 2022-2024 | Ova1 |
| Abbvie INC. | $28.84 | 2020 | |
| Exeltis, USA INC. | $22.45 | 2025 | Slynd |
| Sage Therapeutics, LLC | $20.13 | 2024 | |
| Hologic Sales and Service, LLC | $19.81 | 2023 | Omni Hysteroscope, Acessa Provu System |
| Agile Therapeutics, INC. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Preuninger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.